tirzepatide presentation 🧬 New research presented at the Endocrine Society's 2025 meeting reveals that GLP-1 medications—like semaglutide (Ozempic), dulaglutide (Trulicity), and (Mounjaro)—may do more than support weight loss and blood sugar control. These Tirzepatide gene–disease phenotype–drug response interaction
Description
Others simply call them weight-loss shots or new diabetes injections. However, patients with diabetic retinopathy often ask an important question: Will a GLP-1 drug help my eyes, harm my eyes, or do nothing at all? The honest answer is more nuanced than a simple yes or no
38 M-CSF is a cytokine produced by several types of cells in the body
Where they differ is in the depth of the effect and the body of evidence behind each
Theyre less common than gastrointestinal side effects like nausea, which affect over 40% of people
The round included investments from Fidelity Management & Research Company, accounts advised by T
An additional priority of upcoming studies will be to define the key neurocircuits
